174 related articles for article (PubMed ID: 22289523)
1. Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.
Wu ZM; Teng RY; Shen JG; Xie SD; Xu CY; Wang LB
J Int Med Res; 2011; 39(6):2086-95. PubMed ID: 22289523
[TBL] [Abstract][Full Text] [Related]
2. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy of FLEEOX regimen for unresectable gastric cancer resulting from advanced abdominal lymph nodes metastases].
Li GL; Fan CG; Bao Y; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1171-4. PubMed ID: 20021910
[TBL] [Abstract][Full Text] [Related]
5. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
6. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
Morifuji M; Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Sueda T
Gan To Kagaku Ryoho; 2003 May; 30(5):711-5. PubMed ID: 12795108
[TBL] [Abstract][Full Text] [Related]
8. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
10. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
11. A case of gastric cancer accompanied with massive splenic invasion by metastatic lymph nodes.
Ishida M; Morita S
Jpn J Clin Oncol; 2011 Jul; 41(7):931. PubMed ID: 21719751
[No Abstract] [Full Text] [Related]
12. Tumor Size Improves the Accuracy of the Prognostic Prediction of Lymph Node-Negative Gastric Cancer.
Liang Y; Liu L; Xie X; Xia L; Meng J; Xu R; He D
J Surg Res; 2019 Aug; 240():89-96. PubMed ID: 30913463
[TBL] [Abstract][Full Text] [Related]
13. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.
Bélanger J; Soucy G; Sidéris L; Leblanc G; Drolet P; Mitchell A; Leclerc YE; Beaudet J; Dufresne MP; Dubé P
J Am Coll Surg; 2008 Apr; 206(4):704-8. PubMed ID: 18387477
[TBL] [Abstract][Full Text] [Related]
15. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.
Dong S; Yu JR; Zhang Q; Liu XS
J Chemother; 2016; 28(1):59-64. PubMed ID: 25977986
[TBL] [Abstract][Full Text] [Related]
19. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
20. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.
Kinoshita O; Ichikawa D; Ichijo Y; Komatsu S; Okamoto K; Kishimoto M; Yanagisawa A; Otsuji E
World J Gastroenterol; 2015 Dec; 21(48):13500-6. PubMed ID: 26730161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
